Sortilin, known as a novel mediator in lipid metabolism and glucose regulation, has been implicated in cardiovascular and metabolic diseases, warranting further investigation into its potential impact on metabolic dysfunction in PCOS. This evidence concerns the gene SORT1 and metabolic disease.